PEG
67
5
ORCL
67
2
LEN
52
2
PAYX
51
4
HD
55
8
NKE
30
2
CMCSA
52
4
KHC
11
2
JNJ
44
3
PWR
72
2
MDLZ
36
2
GS
73
7
ABT
62
5
SEE
52
6
ROK
47
-8
PCAR
56
3
KMI
69
2
JWN
42
2
KO
44
2
RIG
58
4
PEG
67
5
ORCL
67
2
LEN
52
2
PAYX
51
4
HD
55
8
NKE
30
2
CMCSA
52
4
KHC
11
2
JNJ
44
3
PWR
72
2
MDLZ
36
2
GS
73
7
ABT
62
5
SEE
52
6
ROK
47
-8
PCAR
56
3
KMI
69
2
JWN
42
2
KO
44
2
RIG
58
4
Financhill
Back

T2 Biosystems Vs. Perspective Therapeutics Industry Stock Comparison

Sell
1

TTOO
T2 Biosystems

Last Price:
0.43
Seasonality Move:
6.82%
Sell
30

CATX
Perspective Therapeutics

Last Price:
2.99
Seasonality Move:
34.33%
Sell
1
T2 Biosystems (TTOO) is a Sell

Is T2 Biosystems a Buy, Sell or Hold?

  • The current T2 Biosystems [TTOO] share price is $0.43. The Score for TTOO is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
  • TTOO is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $3.00. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

TTOO Stock Price Chart

What is T2 Biosystems's stock price today?

  • The T2 Biosystems share price today is $0.43
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TTOO is experiencing selling pressure, which indicates risk of future bearish movement.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $3.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.

TTOO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.29 Sell
Relative Strength Index (14 RSI): 15.37 Sell
Chaikin Money Flow: -355638 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.5 - 1.18) Sell
Bollinger Bands (100): (1.17 - 4.39) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.83 Sell
Relative Strength Index (14 RSI): 9.64 Sell
Chaikin Money Flow: -11653674 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.08 - 12.98) Sell
Bollinger Bands (100): (10.5 - 14.68) Sell

TTOO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.5 Sell
20-day SMA: 0.69 Sell
50-day SMA: 1.37 Sell
200-day SMA: 3.57 Sell
8-day EMA: 0.51 Sell
20-day EMA: 0.74 Sell
50-day EMA: 1.42 Sell
200-day EMA: 13.16 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 7.54 Sell
20-day SMA: 10.1 Sell
50-day SMA: 11.82 Sell
200-day SMA: 12.75 Sell
8-day EMA: 7.04 Sell
20-day EMA: 9.29 Sell
50-day EMA: 11.19 Sell
200-day EMA: 11.43 Sell

T2 Biosystems Earnings Growth & TTOO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.69 per share, a decrease next quarter of $0.00 per share, an increase this year of $20.64 per share, and an increase next year of $1.91 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.78 per share, and a decrease next year of $0.49 per share.

T2 Biosystems Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):